Hot Pursuit     13-Dec-24
Aurobindo Pharma Ltd drops for fifth straight session
Aurobindo Pharma Ltd is quoting at Rs 1198, down 1.37% on the day as on 13:19 IST on the NSE. The stock jumped 14.6% in last one year as compared to a 16.17% rally in NIFTY and a 36.71% spurt in the Nifty Pharma index.

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1198, down 1.37% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.24% on the day, quoting at 24608.35. The Sensex is at 81455.03, up 0.2%.Aurobindo Pharma Ltd has eased around 4.08% in last one month.Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has increased around 1.53% in last one month and is currently quoting at 22229.3, down 0.65% on the day. The volume in the stock stood at 7.22 lakh shares today, compared to the daily average of 10 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 1201.9, down 1.46% on the day. Aurobindo Pharma Ltd jumped 14.6% in last one year as compared to a 16.17% rally in NIFTY and a 36.71% spurt in the Nifty Pharma index.

The PE of the stock is 34.41 based on TTM earnings ending September 24.

Previous News
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-Jan-25   18:01 )
  Aurobindo Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 08-Jan-25   13:35 )
  Aurobindo Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Dec-24   13:05 )
  CuraTeQ Biologics receives UK MHRA approval for oncology biosimilar Bevqolva
 ( Corporate News - 23-Dec-24   16:13 )
  Auro Pharma gets UK MHRA nod for cancer drug
 ( Hot Pursuit - 21-Dec-24   15:20 )
  Auro Pharma’s Telangana unit gets 2 USFDA observations
 ( Hot Pursuit - 18-Dec-24   11:17 )
  Apitoria Pharma's Unit V completes USFDA inspection
 ( Corporate News - 17-Dec-24   19:55 )
  Aurobindo Pharma arm receives positive opinion from EMA for Zefylti
 ( Hot Pursuit - 14-Dec-24   16:18 )
  CuraTeQ Biologics received recommendation of a marketing authorisation for Zefylti
 ( Corporate News - 13-Dec-24   18:31 )
  Aurobindo Pharma Ltd drops for fifth straight session
 ( Hot Pursuit - 13-Dec-24   13:35 )
Other Stories
  Yes Bank Q3 PAT soars 165% YoY to Rs 612 cr
  25-Jan-25   16:32
  Aditya Birla Real Estate partners with Mitsubishi for their residential project in Bengaluru
  25-Jan-25   15:36
  ICICI Bank Q3 PAT grows 15% YoY to Rs 11,792 crore
  25-Jan-25   15:31
  Sharda Cropchem posts PAT of Rs 31 crore in Q3; records volume growth of 49%
  25-Jan-25   14:20
  LMW posts nearly 81% fall in Q3 PAT to Rs 19 crore
  25-Jan-25   13:21
  DLF PAT jumps 61% YoY to Rs 1,059 crore in Q3 FY25
  25-Jan-25   13:18
  Aditya Birla Money Q3 PAT climbs 44% YoY to Rs 22 cr
  25-Jan-25   11:28
  Interglobe Aviation Q3 PAT drops 18% YoY to Rs 2,449 cr
  25-Jan-25   11:22
  Bank of India Q3 PAT climbs 35% YoY to Rs 2512 cr
  25-Jan-25   09:01
  JSW Steel Q3 PAT tumbles 71% YoY to Rs 719 cr
  24-Jan-25   17:43
Back Top